Trials / Terminated
TerminatedNCT03127787
Clinical Performance Evaluation of DxN CMV Assay
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 19 (actual)
- Sponsor
- Beckman Coulter, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The DxN Cytomegalovirus (CMV) assay is an in vitro diagnostic assay intended as an aid in the management of CMV-infected individuals undergoing antiviral therapy. the purpose of the study is to establish the clinical performance of the DxN CMV Assay for plasma samples in the intended use population.
Detailed description
same as brief summary
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | CMV Assay | Molecular diagnostic test to detect CMV |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2017-08-30
- Completion
- 2017-08-30
- First posted
- 2017-04-25
- Last updated
- 2018-07-12
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03127787. Inclusion in this directory is not an endorsement.